Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models

被引：0

作者：

Gowoon Son

Thomas C. Neylan

Lea T. Grinberg

机构：

[1] University of California,Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology

[2] San Francisco,Department of Psychiatry

[3] University of California,Global Brain Health Institute

[4] San Francisco,Department of Pathology

[5] University of California,Department of Pathology

[6] San Francisco,undefined

[7] University of Sao Paulo Medical School,undefined

[8] University of California,undefined

[9] San Francisco,undefined

来源：

Molecular Neurodegeneration | / 19卷

关键词：

“Alzheimer’s disease”; “Progressive supranuclear palsy”; “Neurodegenerative disease”; “Suprachiasmatic nucleus”; “Tau”; “Amyloid”; “Circadian dysregulation”; “Circadian clock”; “Astrocyte”; “Microglia”;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Tauopathies, a group of neurodegenerative diseases that includes Alzheimer’s disease, commonly lead to disturbances in sleep-wake patterns and circadian rhythm disorders. The circadian rhythm, a recurring 24-hour cycle governing human biological activity, is regulated by the hypothalamic suprachiasmatic nucleus (SCN) and endogenous transcriptional-translational feedback loops. Surprisingly, little attention has been given to investigating tauopathy-driven neuropathology in the SCN and the repercussions of SCN and circadian gene dysfunction in the human brain affected by tauopathies. This review aims to provide an overview of the current literature on the vulnerability of the SCN in tauopathies in humans. Emphasis is placed on elucidating the neuronal and glial changes contributing to the widespread disruption of the molecular circadian clock. Furthermore, this review identifies areas of knowledge requiring further investigation.

引用

共 50 条

[31] Neuronal reprogramming of mouse and human fibroblasts using transcription factors involved in suprachiasmatic nucleus development
Hirayama, Masatoshi
Mure, Ludovic S.
Le, Hiep D.
Panda, Satchidananda
ISCIENCE, 2024, 27 (03)
[32] Pathogenesis evidence from human and animal models of detrusor underactivity
Jhang, Jia-Fong
Jiang, Yuan-Hong
Hsu, Yung-Hsiang
Ho, Han-Chen
Kuo, Hann-Chorng
TZU CHI MEDICAL JOURNAL, 2022, 34 (03): : 287 - 296
[33] The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models
Egana-Huguet, Jon
Soria-Gomez, Edgar
Grandes, Pedro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
[34] Genetic contributions to myopic refractive error: Insights from human studies and supporting evidence from animal models
Hawthorne, Felicia A.
Young, Terri L.
EXPERIMENTAL EYE RESEARCH, 2013, 114 : 141 - 149
[35] Evidence from animal models
Nehlig, A.
EPILEPSIA, 2006, 47 : 263 - 263
[36] Endoplasmic Reticulum Stress in Tauopathies: Contrasting Human Brain Pathology with Cellular and Animal Models
Bocai, Nadia, I
Marcora, Maria S.
Belfiori-Carrasco, Lautaro F.
Morelli, Laura
Castano, Eduardo M.
JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 439 - 458
[37] UNALTERED NEURONAL AND GLIAL COUNTS IN ANIMAL MODELS OF MAGNETIC SEIZURE THERAPY AND ELECTROCONVULSIVE THERAPY
Dwork, A. J.
Christensen, J. R.
Larsen, K. B.
Scalia, J.
Underwood, M. D.
Arango, V.
Pakkenberg, B.
Lisanby, S. H.
NEUROSCIENCE, 2009, 164 (04) : 1557 - 1564
[38] Oxidative stress in phenylketonuria—evidence from human studies and animal models, and possible implications for redox signaling
Vanessa Trindade Bortoluzzi
Carlos Severo Dutra Filho
Clovis Milton Duval Wannmacher
Metabolic Brain Disease, 2021, 36 : 523 - 543
[39] Neuronal plasticity in animal models and the epileptic human hippocampus
Sperk, Gunther
Drexel, Meinrad
Pirker, Susanne
EPILEPSIA, 2009, 50 : 29 - 31
[40] Nicotine addiction: studies about vulnerability, epigenesis and animal models
Pastor, Veronica
Vazquez, Pablo
Corapi, Enrique
Bernabeu, Ramon
REVISTA ARGENTINA DE CIENCIAS DEL COMPORTAMIENTO, 2013, 5 (02): : 61 - 73

← 1 2 3 4 5 →